Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.
Financial Statements
- Click here to download Edwards Lifesciences Corp's Income Statement
- Click here to download Edwards Lifesciences Corp's Balance Sheet
- Click here to download Edwards Lifesciences Corp's Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name:
Key Statistics
- Stock Price: $103.57
- Dividend Yield: 0%
- Market Capitalization: $64,395,353,729
- Shares Outstanding: 621,636,777
- Number of Employees: 0
- Trailing 12-Month EPS: $1.35
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2021-07-22
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $103.57
- 52-week high: $105.58
- 52-week low: $66.87
- 200-day moving average: $89.2
- 50-day moving average: $97.02
Performance
- 1-Month Price Return: 8.0%
- 3-Month Price Return: 25.7%
- 6-Month Price Return: 15.1%
- 1-Year Price Return: 52.6%
- 2-Year Price Return: 68.2%
- 5-Year Price Return: 220.7%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast